Qualified bulk reagent becomes a usable diagnostic product only after it has been filled accurately, matched with the correct components, labeled clearly, and protected by suitable packaging. Errors at this stage can affect reagent stability, usable test volume, component traceability, and the end user's ability to perform the assay correctly.
As part of our IVD reagent and kit contract manufacturing service, Creative Enzymes Diagnostic provides filling, kitting, and packaging support for liquid, frozen, lyophilized, and dry diagnostic reagents. Services can be configured for development lots, pilot batches, validation-related production, or routine supply, with controls for dispensing, closure, assembly, labeling, inspection, and batch documentation.

Projects may begin with client-supplied bulk reagent, materials manufactured by Creative Enzymes Diagnostic, or a complete set of kit components. The production configuration is defined around reagent properties, fill volume, container, number of components, storage condition, labeling requirements, and planned batch size.
| Service Area | Typical Support |
|---|---|
| Reagent Filling | Controlled dispensing of liquid, frozen, concentrated, or pre-lyophilization reagents into bottles, vials, tubes, cartridges, or other approved containers. |
| Component Preparation | Aliquoting, closure, labeling, and staging of controls, calibrators, substrates, buffers, enzyme solutions, conjugates, and auxiliary components. |
| Kit Assembly | Matching and assembly of reagent components, consumables, accessories, and instructions in the approved kit configuration. |
| Packaging | Primary, secondary, and shipping packaging selected to support stability, handling, storage, and distribution. |
| Labeling and Traceability | Controlled use of product, component, lot, expiration, storage, barcode, and customer-approved label information. |
| Inspection and Release Support | Fill checks, visual inspection, closure verification, component reconciliation, kit completeness, and batch-record review. |
Filling parameters are established according to reagent viscosity, foaming tendency, temperature sensitivity, adsorption risk, required usable volume, and container geometry. The process is designed to achieve consistent fill quantity while limiting unnecessary exposure to air, light, heat, or repeated handling.
Formats Supported
Process Controls
Small-volume reagents require particular attention to equipment accuracy, dead volume, evaporation, and material loss on tubing or container surfaces. For active proteins and enzymes, dispensing conditions may also be adjusted to reduce foaming, shear, repeated warming, or prolonged room-temperature exposure. Pilot filling can be used to confirm recovery and functional activity before larger production runs.
For reagents filled before freeze-drying, the process coordinates target fill, partial stoppering where applicable, lyophilization handling, final closure, and post-process inspection. Release testing may include cake appearance, reconstitution time, residual moisture where required, fill consistency, and functional assay response after rehydration.
Diagnostic kits may contain reagents with different lots, expiration periods, storage needs, and quantities. A controlled bill of materials defines every component and its approved version. Before assembly, components are verified for identity, release status, lot, quantity, and compatibility with the planned finished-kit expiration.
During kitting, component counts and lot combinations are recorded, and unused materials are reconciled. Line clearance between products or configurations helps prevent carryover of labels, inserts, or components from a previous assembly run.
Packaging must protect reagent performance while remaining practical for filling, storage, shipping, and use. Selection considers chemical compatibility, light sensitivity, evaporation, moisture ingress, oxygen exposure, breakage risk, cold-chain conditions, and the number of times a container will be opened.
Primary Packaging
Secondary and Shipping Packaging
Compatibility checks may examine adsorption, leakage, evaporation, closure integrity, extractable-related risk, discoloration, precipitation, and changes in functional performance. The scope is matched to the reagent and development stage. When a packaging change is proposed, comparative stability or performance testing may be needed before routine implementation.
Labels and printed components are managed by approved version and product configuration. Information may include product identity, component name, catalog number, lot, expiration date, storage condition, volume, barcode, and customer-approved branding. Variable data are checked against the batch and kit records before use.
Traceability links incoming materials and bulk reagent lots to filled components and finished kits. Where several component lots are combined, the relationship is documented so that affected kits can be identified efficiently if a question arises later.
Inspection points are selected according to the product's main failure risks. Checks can be performed during filling, labeling, assembly, and final release rather than relying only on end-of-line inspection.
In-Process Checks
Finished-Kit Checks

| Item | Description |
|---|---|
| Approved Filling and Kit Configuration | Defined containers, fill quantities, component list, label versions, packaging materials, inspection points, and storage conditions. |
| Filled Reagents or Assembled Kits | Development, pilot, or routine-production units prepared in the agreed format and batch quantity. |
| Production and Reconciliation Records | Records of bulk lots, component lots, quantities used, filling or assembly results, yields, and material reconciliation. |
| Inspection and Traceability Records | Available fill checks, label verification, closure inspection, kit-completeness results, and component-to-finished-kit traceability. |
| Packaging and Storage Recommendation | Selected packaging configuration and available compatibility, handling, storage, or shipping recommendations. |
| Batch Release Documentation | Agreed batch summary, finished-kit inspection results, deviations, and release-related records. |
Q1. Can you fill diagnostic reagents manufactured by another supplier?
Q2. Do you support small development or pilot batches?
Q3. Can different component lots be combined in one finished kit?
Q4. How is the correct packaging selected for a reagent?
Q5. Can you use our existing labels, cartons, and instructions?
Creative Enzymes Diagnostic provides controlled downstream production support that connects qualified bulk reagents with consistent filling, accurate kit assembly, clear labeling, protective packaging, and lot-level traceability. Services can be scaled from development lots to recurring finished-kit supply according to the product configuration.
Contact our business development team today to discuss your diagnostic reagent filling, kitting, and packaging needs!